concept

COGNITIVE DECLINE

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about COGNITIVE DECLINE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

586Connections

9Hypotheses

30Analyses

50Outgoing

50Incoming

0Experiments

20Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	COGNITIVE DECLINE
Key Genes/Proteins	AMYLOID, AMYLOID-BETA, APOE4, APP, BDNF
Related Diseases	AGING, ALZHEIMER'S DISEASE, AUTOPHAGY

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Cholinergic Neurons in Cognitive Decline

cell · 659 words

→

Pathway Diagram

graph TD
    COGNITIVE_DECLINE["COGNITIVE DECLINE"]
    style COGNITIVE_DECLINE fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
    Parkinson_s_Disease["Parkinson's Disease"] -->|"causes"| COGNITIVE_DECLINE
    Lecanemab{"Lecanemab"} -->|"treats"| COGNITIVE_DECLINE
    Donanemab{"Donanemab"} -->|"treats"| COGNITIVE_DECLINE
    Alzheimer_s_Disease["Alzheimer's Disease"] -->|"causes"| COGNITIVE_DECLINE
    Postoperative_Cognitive_Dysfun["Postoperative Cognitive Dysfunction"] -->|"causes"| COGNITIVE_DECLINE
    Type_2_Diabetes_Mellitus["Type 2 Diabetes Mellitus"] -->|"causes"| COGNITIVE_DECLINE
    Cognitive_Resilience(Cognitive Resilience) -.->|"protects against"| COGNITIVE_DECLINE
    LRP1_targeted_Polymersomes["LRP1-targeted Polymersomes"] -.->|"protects against"| COGNITIVE_DECLINE
    APOE4([APOE4]) -->|"risk_factor_for"| COGNITIVE_DECLINE
    Tau_Pathology["Tau Pathology"] -->|"causes"| COGNITIVE_DECLINE

Outgoing (85)

Target	Relation	Type	Str
Alzheimer's Disease	associated_with	disease	0.95
Alzheimer'S Disease	associated_with	disease	0.95
Alzheimer's Disease	associated_with	disease	0.95
Alzheimer's Disease	biomarker_for	disease	0.90
tangle pathology	associated_with	phenotype	0.70
NEUROGENESIS	increases_risk	phenotype	0.70
STROKE	stabilizes	disease	0.70
STROKE	inhibits	disease	0.70
STROKE	activates	disease	0.70
STROKE	treats	disease	0.70
STROKE	protects_against	disease	0.70
ADUCANUMAB	interacts_with	drug	0.70
TAU	regulates	protein	0.70
NEURODEGENERATION	stabilizes	phenotype	0.70
senescent neuron burden	biomarker_for	cell_type	0.70
AMYLOID	associated_with	protein	0.65
STROKE	interacts_with	disease	0.65
NEURODEGENERATION	treats	disease	0.65
NEURONS	exacerbates	cell_type	0.65
AMYLOID PET	regulates	biomarker	0.65
NEURODEGENERATION	regulates	disease	0.65
SYNAPTIC PLASTICITY	regulates	phenotype	0.65
NECROPTOSIS	inhibits	phenotype	0.65
TAU	activates	protein	0.65
NEUROGENESIS	activates	phenotype	0.65
SYNAPTIC PLASTICITY	treats	phenotype	0.65
METFORMIN	activates	drug	0.65
NLRP3 INFLAMMASOME	regulates	pathway	0.65
SYNAPTIC PLASTICITY	activates	phenotype	0.65
ALZHEIMER'S DISEASE	increases_risk	disease	0.65
NLRP3	inhibits	gene	0.65
CREB	targets	gene	0.65
NLRP3	activates	gene	0.65
NEURODEGENERATION	biomarker_for	disease	0.60
CSF	stabilizes	phenotype	0.60
CSF	inhibits	phenotype	0.60
ALZHEIMER'S DISEASE	implicated_in	disease	0.55
ALZHEIMER'S DISEASE	expressed_in	disease	0.55
FDG-PET	associated_with	biomarker	0.50
ENTORHINAL CORTEX	associated_with	brain_region	0.50
AMYLOID-β	interacts_with	concept	0.50
MTOR SIGNALING	activates	concept	0.50
WHITE MATTER	associated_with	brain_region	0.50
ADUCANUMAB	associated_with	drug	0.50
SEMAGLUTIDE	associated_with	drug	0.50
ENDOTHELIAL CELLS	inhibits	concept	0.50
AMYLOID-β	causes	concept	0.50
FRONTAL	inhibits	concept	0.50
RAPAMYCIN	associated_with	drug	0.50
HYPOTHALAMUS	associated_with	brain_region	0.50

Incoming (501)

Source	Relation	Type	Str
APOE4	predicts	gene	1.00
Parkinson's Disease	causes	disease	0.95
Alzheimer'S Disease	causes	disease	0.95
Postoperative Cognitive Dysfunction	causes	disease	0.95
Lecanemab	treats	drug	0.95
Obesity	causes	disease	0.95
alzheimer_disease	causes	disease	0.95
Donanemab	treats	drug	0.95
Alzheimer's Disease	causes	disease	0.95
APOE	associated_with	gene	0.95
T2DM	associated_with	disease	0.95
FTO	inhibits	gene	0.95
ALZHEIMER'S DISEASE	causes	disease	0.95
Bd-Tau	biomarker_for	biomarker	0.93
P-Tau+/Bd-Tau+ Profile	risk_factor_for	biomarker	0.93
Cognitive Resilience	protects_against	phenotype	0.92
LRP1-targeted Polymersomes	protects_against	compound	0.92
Type 2 Diabetes Mellitus	causes	disease	0.92
synaptic_loss	causes	phenotype	0.90
Bioenergetics	drives	pathway	0.90
synaptic_loss	associated_with	phenotype	0.90
neuronal loss	causes	phenotype	0.90
APOE4	associated_with	protein	0.90
Chronic Inflammation	contributes_to	mechanism	0.90
tau neurofibrillary tangles	causes	entity	0.90
ERK	prevents	protein	0.90
Parkinson'S Disease	causes	disease	0.90
Tau Protein Hyperphosphorylation	causes	mechanism	0.90
39559873	did not demonstrate efficacy in preventing	paper	0.90
Amyloid-beta	causes	protein	0.90
APOE	associated_with	entity	0.90
Amyloid Beta	contributes_to	protein	0.90
Ginsenoside Compound K	associated_with	compound	0.90
Ageing	causes	process	0.90
Neurodegeneration	causes	process	0.90
soluble_tau_oligomers	biomarker_for	protein	0.90
glymphatic_clearance	correlates_with	mechanism	0.90
High-Fat Diet	causes	process	0.90
TNF-α/NF-κB/NLRP3	causes	pathway	0.90
Parkinson Disease	associated_with	disease	0.90
Histone Deacetylation	causes	process	0.90
APOE ε4	causes	gene	0.90
Tau Pathology	causes	process	0.90
Defective Insulin Signaling	causes	process	0.90
Physical Exercise	protects_against	process	0.90
27235538	is age-associated and occurs before	paper	0.90
mitochondrial DNA release	contributes_to	mechanism	0.90
24813892	is the primary risk factor for	paper	0.90
gamma oscillations	biomarker_for	process	0.90
APOE-ε4	associated_with	gene	0.90

Targeting Hypotheses (9)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Complement C1q-Mediated Synaptic Pruning Drives Early Cognit	0.769	neurodegeneration	Legacy Pre-Pipeline Hypothesis Import
Circulating Soluble PDGFRβ Reflects Pericyte Loss and Preced	0.745	-	What blood-brain barrier permeability ch
sex-divergent microglial activation states and X-linked immu	0.626	neurodegeneration	Sex-Specific Microglial States in Amyloi
DPP6-linked neuronal regulatory networks controlling synapti	0.626	neurodegeneration	DPP6 GWAS Signal: Cell-Type Regulatory N
Circulating Soluble PDGFRβ Reflects Pericyte Loss and Preced	0.625	-	What blood-brain barrier permeability ch

Cell-state stratification is required to resolve DPP6 GWAS S	0.612	neurodegeneration	DPP6 GWAS Signal: Cell-Type Regulatory N
Cell-state stratification is required to resolve Sex-Specifi	0.612	neurodegeneration	Sex-Specific Microglial States in Amyloi
Perturbation-first validation should precede therapeutic cla	0.608	neurodegeneration	Sex-Specific Microglial States in Amyloi
Perturbation-first validation should precede therapeutic cla	0.608	neurodegeneration	DPP6 GWAS Signal: Cell-Type Regulatory N

Mentioning Analyses (30)

Scientific analyses that reference this entity

Methodology challenge: dataset 'Allen Brain SEA-AD Single Cell Dataset' — evalua

neurodegeneration | 2026-04-28 | 7 hypotheses Top: 0.662

Sex-Specific Microglial States in Amyloid vs Tau Pathology and Cognitive Decline

neurodegeneration | 2026-04-27 | 4 hypotheses Top: 0.675

What is the optimal dosage and timing of melatonin administration for AD prevent

neurodegeneration | 2026-04-26 | 7 hypotheses Top: 0.735

What blood-brain barrier permeability changes serve as early biomarkers for neur

neurodegeneration | 2026-04-26 | 8 hypotheses Top: 0.940

What blood-brain barrier permeability changes serve as early biomarkers for neur

neurodegeneration | 2026-04-26 | 8 hypotheses Top: 0.745

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (4)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Young adult microglial deletion of C1q reduces engulfment of synapses and preven [PMID:41000995]	Petrisko TJ, Chu SH, Gomez-Arboledas A,	bioRxiv : the preprint server	2025	1
The Role of Complement in Synaptic Pruning and Neurodegeneration. [PMID:34595138]	Gomez-Arboledas A, Acharya MM, Tenner AJ	ImmunoTargets and therapy	2021	1
Pioglitazone attenuates complement-mediated microglial synaptic engulfment in an [PMID:41396874]	Unknown	Brain : a journal of neurology	2026	0
C5aR1 signaling promotes region- and age-dependent synaptic pruning in models of [PMID:38278523]	["Angela Gomez-Arboledas", "Maria I Fons	Alzheimer's & dementia : t	2024	0

Debates (20)

Multi-agent debates referencing this entity

Methodology challenge: dataset 'Allen Brain SEA-AD Single Cell Dataset' — evalua

active · Rounds: 4 · Score: 0.76 · 2026-04-28

What sex-specific microglial transcriptional states emerge in response to amyloi

active · Rounds: 4 · Score: 0.67 · 2026-04-28

Extended debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Extended debate: Closed-loop transcranial focused ultrasound with 40Hz gamma ent

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Extended debate: Closed-loop tACS targeting EC-II SST interneurons to block tau

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Debate: Closed-loop transcranial focused ultrasound targeting entorhinal PV inte

closed · Rounds: 4 · Score: 0.65 · 2026-04-27

Debate: TREM2 R47H Metabolic Lock-in at Cholesterol Ester Accumulation

closed · Rounds: 4 · Score: 0.59 · 2026-04-27

Debate: Closed-loop tACS targeting EC-II SST interneurons to block tau propagati

closed · Rounds: 4 · Score: 0.71 · 2026-04-27

Debate: Closed-loop transcranial focused ultrasound to restore hippocampal gamma

closed · Rounds: 4 · Score: 0.87 · 2026-04-27

Debate: Closed-loop tACS targeting EC-II PV interneurons to suppress burst firin

closed · Rounds: 4 · Score: 0.48 · 2026-04-27

Related Research

Hypotheses and analyses mentioning COGNITIVE DECLINE in their description or question text

Cell-state stratification is required to resolve DPP6 GWAS Signal: Cell-Type Reg

Score: 0.612 · neurodegeneration · 2026-04-28

The question is likely underpowered or misleading unless analyses preserve the key strata: DPP6, GWAS. Averaging across

Cell-state stratification is required to resolve Sex-Specific Microglial States

Score: 0.612 · neurodegeneration · 2026-04-28

The question is likely underpowered or misleading unless analyses preserve the key strata: amyloid-beta. Averaging acros

Perturbation-first validation should precede therapeutic claims for Sex-Specific

Score: 0.608 · neurodegeneration · 2026-04-28

The debate supports treating this as a validation program before ranking it as a therapy. Perturbation should move a pro

Perturbation-first validation should precede therapeutic claims for DPP6 GWAS Si

Score: 0.608 · neurodegeneration · 2026-04-28

The debate supports treating this as a validation program before ranking it as a therapy. Perturbation should move a pro

COGNITIVE DECLINE

Understanding Entity Pages

Wiki Pages (1)

Cholinergic Neurons in Cognitive Decline

Pathway Diagram

Outgoing (85)

Incoming (501)

Targeting Hypotheses (9)

Mentioning Analyses (30)

Methodology challenge: dataset 'Allen Brain SEA-AD Single Cell Dataset' — evalua

Sex-Specific Microglial States in Amyloid vs Tau Pathology and Cognitive Decline

What is the optimal dosage and timing of melatonin administration for AD prevent

What blood-brain barrier permeability changes serve as early biomarkers for neur

What blood-brain barrier permeability changes serve as early biomarkers for neur

Neuroinflammation Biomarker Panel for Early AD Detection

Proteomics Differential Expression in AD CSF and Brain Tissue

Spatial Transcriptomics Analysis of Alzheimer's Disease Brain Regions

What amyloid threshold level is required for optimal clinical benefit in early A

Systemic immune profiling in neurodegeneration: peripheral inflammation as drive

Quantitative proteomics of the aging synapse: protein turnover and aggregation i

What is the temporal sequence of TREM2 signaling transition from protective to i

What are the precise temporal dynamics of astrocyte ketone production decline du

What are the specific circulating factors in exercise-conditioned plasma that me

How can functional hyperconnectivity patterns distinguish compensatory mechanism

Why have numerous phase 3 clinical trials failed despite advances in understandi

What specific gene expression signatures in aging mouse brain predict human AD v

What specific gene expression signatures in aging mouse white matter predict hum

Do tau aggregates represent protective responses or primary pathogenic drivers i

What evidence supports Cdk5 activation as THE primary cause of AD versus other e

Investigate mechanisms of epigenetic reprogramming in aging neurons, including D

What is the optimal therapeutic window during preclinical AD for epigenetic repr

How does P2RY12-mediated VSMC dysfunction contribute to cerebrovascular neurodeg

Does SPP1-mediated synaptic engulfment represent beneficial clearance or patholo

How can senescent microglia be molecularly distinguished from beneficial activat

How do disease-associated mutations in G3BP1 or its binding partners alter stres

Lipid metabolism dysregulation and membrane integrity in Alzheimer disease

Senescent cell clearance as neurodegeneration therapy

Circuit-level neural dynamics in neurodegeneration

Cell type vulnerability in Alzheimers Disease (SEA-AD transcriptomic data)

Experiments (0)

Related Papers (4)

Debates (20)

Methodology challenge: dataset 'Allen Brain SEA-AD Single Cell Dataset' — evalua

What sex-specific microglial transcriptional states emerge in response to amyloi

Extended debate: Metabolic Reprogramming to Reverse Senescence

Extended debate: Closed-loop transcranial focused ultrasound with 40Hz gamma ent

Extended debate: Closed-loop tACS targeting EC-II SST interneurons to block tau

Debate: Closed-loop transcranial focused ultrasound targeting entorhinal PV inte

Debate: TREM2 R47H Metabolic Lock-in at Cholesterol Ester Accumulation

Debate: Closed-loop tACS targeting EC-II SST interneurons to block tau propagati

Debate: Closed-loop transcranial focused ultrasound to restore hippocampal gamma

Debate: Closed-loop tACS targeting EC-II PV interneurons to suppress burst firin

Related Research

Cell-state stratification is required to resolve DPP6 GWAS Signal: Cell-Type Reg

Cell-state stratification is required to resolve Sex-Specific Microglial States

Perturbation-first validation should precede therapeutic claims for Sex-Specific

Perturbation-first validation should precede therapeutic claims for DPP6 GWAS Si